202 related articles for article (PubMed ID: 23907124)
1. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma.
Martins D; Beça FF; Sousa B; Baltazar F; Paredes J; Schmitt F
Cell Cycle; 2013 Aug; 12(16):2684-90. PubMed ID: 23907124
[TBL] [Abstract][Full Text] [Related]
2. Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer.
Lisanti MP; Sotgia F; Pestell RG; Howell A; Martinez-Outschoorn UE
Cell Cycle; 2013 Sep; 12(18):2935-6. PubMed ID: 23989616
[No Abstract] [Full Text] [Related]
3. The relationship between the expressions of tumor associated fibroblasts Cav-1 and MCT4 and the prognosis of papillary carcinoma of breast.
Zhai Y; Chai L; Chen J
Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):263-272. PubMed ID: 28625953
[TBL] [Abstract][Full Text] [Related]
4. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.
Martinez-Outschoorn UE; Curry JM; Ko YH; Lin Z; Tuluc M; Cognetti D; Birbe RC; Pribitkin E; Bombonati A; Pestell RG; Howell A; Sotgia F; Lisanti MP
Cell Cycle; 2013 Aug; 12(16):2580-97. PubMed ID: 23860378
[TBL] [Abstract][Full Text] [Related]
5. Expression of Cav-1, MCT1, and MCT4 in Ductal Carcinoma In Situ of the Breast and Their Associations With Clinicopathologic Features.
Kim NI; Park MH; Lee JS
Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):204-212. PubMed ID: 36867736
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies.
Martinez-Outschoorn UE; Balliet R; Lin Z; Whitaker-Menezes D; Birbe RC; Bombonati A; Pavlides S; Lamb R; Sneddon S; Howell A; Sotgia F; Lisanti MP
Cell Cycle; 2012 Dec; 11(23):4402-13. PubMed ID: 23172369
[TBL] [Abstract][Full Text] [Related]
8. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.
Witkiewicz AK; Whitaker-Menezes D; Dasgupta A; Philp NJ; Lin Z; Gandara R; Sneddon S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2012 Mar; 11(6):1108-17. PubMed ID: 22313602
[TBL] [Abstract][Full Text] [Related]
9. Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer.
Monti D; Sotgia F; Whitaker-Menezes D; Tuluc M; Birbe R; Berger A; Lazar M; Cotzia P; Draganova-Tacheva R; Lin Z; Domingo-Vidal M; Newberg A; Lisanti MP; Martinez-Outschoorn U
Semin Oncol; 2017 Jun; 44(3):226-232. PubMed ID: 29248134
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
[TBL] [Abstract][Full Text] [Related]
11. Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer.
Witkiewicz AK; Dasgupta A; Nguyen KH; Liu C; Kovatich AJ; Schwartz GF; Pestell RG; Sotgia F; Rui H; Lisanti MP
Cancer Biol Ther; 2009 Jun; 8(11):1071-9. PubMed ID: 19502809
[TBL] [Abstract][Full Text] [Related]
12. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
Sharma M; Beck AH; Webster JA; Espinosa I; Montgomery K; Varma S; van de Rijn M; Jensen KC; West RB
Breast Cancer Res Treat; 2010 Sep; 123(2):397-404. PubMed ID: 19949854
[TBL] [Abstract][Full Text] [Related]
13. The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer.
Koo JS; Park S; Kim SI; Lee S; Park BW
Tumour Biol; 2011 Aug; 32(4):787-99. PubMed ID: 21584795
[TBL] [Abstract][Full Text] [Related]
14. Host response to human breast Invasive Ductal Carcinoma (IDC) as observed by changes in the stromal proteome.
Reddy LA; Mikesh L; Moskulak C; Harvey J; Sherman N; Zigrino P; Mauch C; Fox JW
J Proteome Res; 2014 Nov; 13(11):4739-51. PubMed ID: 25244421
[TBL] [Abstract][Full Text] [Related]
15. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
[TBL] [Abstract][Full Text] [Related]
16. A reverse Warburg metabolism in oral squamous cell carcinoma is not dependent upon myofibroblasts.
Jensen DH; Therkildsen MH; Dabelsteen E
J Oral Pathol Med; 2015 Oct; 44(9):714-21. PubMed ID: 25420473
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.
Whitaker-Menezes D; Martinez-Outschoorn UE; Lin Z; Ertel A; Flomenberg N; Witkiewicz AK; Birbe RC; Howell A; Pavlides S; Gandara R; Pestell RG; Sotgia F; Philp NJ; Lisanti MP
Cell Cycle; 2011 Jun; 10(11):1772-83. PubMed ID: 21558814
[TBL] [Abstract][Full Text] [Related]
18. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.
Ayala G; Morello M; Frolov A; You S; Li R; Rosati F; Bartolucci G; Danza G; Adam RM; Thompson TC; Lisanti MP; Freeman MR; Vizio DD
J Pathol; 2013 Sep; 231(1):77-87. PubMed ID: 23729330
[TBL] [Abstract][Full Text] [Related]
19. Stromal-epithelial metabolic coupling in gastric cancer: stromal MCT4 and mitochondrial TOMM20 as poor prognostic factors.
Zhao Z; Han F; He Y; Yang S; Hua L; Wu J; Zhan W
Eur J Surg Oncol; 2014 Oct; 40(10):1361-8. PubMed ID: 24821064
[TBL] [Abstract][Full Text] [Related]
20. Metabolic coupling in phyllodes tumor of the breast and its association with tumor progression.
Kim NI; Park MH; Kweon SS; Lee JS
Oncol Lett; 2023 Dec; 26(6):545. PubMed ID: 38020291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
